Elon’s Anthropic Deal, The Next AI Monopoly?, “FDA for AI” Panic, Trading the AI Boom
All-In debates Elon’s AI infrastructure play, Anthropic’s rise, AI regulation fears, and whether the AI boom is already showing up in the economy
Breaking the Memory Wall: Micron’s Strategy for the AI Era
Micron argues AI is creating a durable memory and storage boom beyond the usual chip cycle.
Sam Altman's Vision For the Future!
Sam Altman outlines a future where AI becomes a personalized creative partner, a scientific discovery engine, and a new computing platform.
OpenAI Misses Targets, Codex vs Claude, Elon vs Sam Trial, Big Hyperscaler Beats, Peptide Craze
AI execution, infrastructure bottlenecks, legal risk, and biotech hype dominate a wide-ranging All-In episode
Google Invests $40B Into Anthropic, GPT 5.5 Drops, and Google Cloud Dominates | EP #252
A fast-moving tour of frontier AI releases, cloud-scale compute battles, and the rising pressure on privacy, jobs, and healthcare
Stock Expert: Becoming Rich Is Simple, But You Won’t Do It!
A behavior-first guide to wealth: earn more, invest simply, and avoid costly mistakes
Demis Hassabis: Agents, AGI & The Next Big Scientific Breakthrough
Demis Hassabis argues that AGI is close, but still missing a few crucial capabilities, while AI’s biggest near-term impact may be scientific discovery.
Google Cloud CEO: Anthropic, TPUs, Mythos, NVIDIA and more
Google Cloud’s AI stack bets on TPUs, inference demand, and full-stack co-design
SpaceX-Cursor Deal, SaaS Debt Bomb, New Apple CEO, SPLC Indictment, Colon Cancer Spike
All-In covers AI dealmaking, SaaS fragility, Apple succession, nonprofit misconduct allegations, and a public-health science corner.
The Supply and Demand of AI Tokens | Dylan Patel Interview
AI tokens are becoming a strategic bottleneck, reshaping software, infrastructure, and even public debate
Elon's $60B Cursor Bet, Claude kills SaaS, and OpenAI's Mass Departures | EP #249
Frontier AI is moving from software features to platform power, with major implications for jobs, startups, and infrastructure
GLP-1s, Peptides, and The Trillion-Dollar Health Revolution
A sweeping case that GLP-1s may be the first proof point of a much broader health and longevity revolution
Sam Altman’s Attack, Amazon vs. Starlink, and What Opus 4.7 Actually Means | #248
AI progress, social backlash, and the next wave of human-machine transformation
The GPT Moment for Robotics Is Here
Robotics is nearing a foundation-model inflection point, with cloud-controlled systems, cross-embodiment learning, and real warehouse deployments suggesting the field is moving from demos to scalable products.
Elon Musk vs. Sam Altman, AI Job Loss, and OpenAI’s $852B Valuation | EP #247
A wide-ranging AI megatrends episode on frontier lab power struggles, job displacement, energy abundance, biotech acceleration, robotics, quantum risk, and the next wave of scientific breakthroughs.